Livemint EN

Innovision IPO Day 2: Issue sees tepid demand as GMP remains weak. Should you apply or not?

Innovision IPO GMP today is nil. This means that shares of Innovision are trading at par with the IPO price. At the prevailing GMP, Innovision IPO listing price will be the same as the offer price. Shares of Innovision IPO are slated to list on both BSE and NSE on March 17.

Mar 11, 2026 &03341111202631; 04:34 UTC www.livemint.com Trending 3/5

Read original on www.livemint.com ↗

↘

Negative for markets

Sentiment score: -45/100

Moderate impact Short-term (days)

WHAT THIS MEANS

Innovision IPO shows weak demand on Day 2 with nil GMP (Grey Market Premium), indicating shares are trading at par with the IPO offer price. This suggests limited investor enthusiasm and potential for a flat or negative listing on March 17, 2025.

AI CONFIDENCE

75% High

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↓

INNOVISION

INNOVISIONStock

Expected to decline

Nil GMP indicates weak market demand and investor skepticism; listing likely to be flat or negative

⇅

FTSE MIB (Italy)

FTSEMIB.MIIndex

High volatility expected

Indian IPO weakness may signal broader market sentiment concerns in emerging markets

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

Avoid applying to Innovision IPO unless you have strong conviction in the company's fundamentals. The nil GMP and weak demand suggest limited upside potential at listing; consider waiting for post-listing price discovery before entering.

KEY SIGNALS

Nil GMP indicates zero premium expectationsTepid demand on Day 2 suggests weak investor interestPar trading with offer price signals lack of enthusiasmListing scheduled for March 17, 2025

SECTORS INVOLVED

TechnologyIPO MarketCapital Markets

Analysis generated on Mar 11, 2026 at 04:48 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Livemint. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Innovision IPO Day 2: Issue sees tepid demand as GMP remains weak. Should you apply or not?

RELATED INTELLIGENCE